Cell Marque Portfolio

Ki-67 (SP6)

Rabbit Monoclonal


The Ki-67 antigen is a nuclear, non-histone protein that is present in proliferating cells. In general, Ki-67 is a good marker of proliferating cell populations. Anti-Ki-67 labeling index has been shown to be a good marker to grade neoplasms including: astrocytoma, oligodendroglioma, colon carcinoma, breast carcinoma, lymphoma and sarcoma.1-5

Specialties: Anatomic Pathology Breast/Gynecological Pathology

Specifications


  • Reactivity: paraffin
  • Visualization: nuclear
  • Control: tonsil
  • Isotype: lgG
  • Dilution Range: 1:100-1:500*

Protocols


  • Cell Marque HiDef
    T-PC/10-30minAb/HiDef/Perm Red
  • Cell Marque HiDef
    T-PC/10-30minAb/HiDef/DAB
  • Ventana ultraView
    UV/CC1S/32min @ 37°C

Package Inserts


Select revision:


SDS

References


  1. Mckeever P, et al. J Neuropathol Exp Neurol. 1998; 57:931-6.
  2. Coons SW, et al. Neurosurgery. 1997; 41:878-84.
  3. Allegra CJ, et al. J Clin Oncol. 2003; 21:241-50.
  4. Pathmanathan N, et al. J Clin Pathol. 2013; 66: 512-6.
  5. Swerdlow S, et al. WHO clarifications of tumours of hematopoietic and lymphoid tissues. 4th edition, 2008. P 220.

Last updated: 2017-05-24 08:46:09

Ki-67
Ki-67 (SP6) on tonsil.

Mouse over to zoom, use scroll wheel to zoom in/out

Tap image once to activate zoom lens

Specifications


  • Reactivity: paraffin
  • Visualization: nuclear
  • Control: tonsil
  • Isotype: lgG
  • Dilution Range: 1:100-1:500*

Protocols


  • Cell Marque HiDef
    T-PC/10-30minAb/HiDef/Perm Red
  • Cell Marque HiDef
    T-PC/10-30minAb/HiDef/DAB
  • Ventana ultraView
    UV/CC1S/32min @ 37°C

References


  1. Mckeever P, et al. J Neuropathol Exp Neurol. 1998; 57:931-6.
  2. Coons SW, et al. Neurosurgery. 1997; 41:878-84.
  3. Allegra CJ, et al. J Clin Oncol. 2003; 21:241-50.
  4. Pathmanathan N, et al. J Clin Pathol. 2013; 66: 512-6.
  5. Swerdlow S, et al. WHO clarifications of tumours of hematopoietic and lymphoid tissues. 4th edition, 2008. P 220.

Package Inserts

Select revision:



Ordering Information

For in vitro diagnostic (IVD) use in USA

0.1 mL concentrate 275R-14
0.5 mL concentrate 275R-15
1 mL concentrate 275R-16
1 mL predilute 275R-17
7 mL predilute 275R-18
25 mL predilute 275R-10

For in vitro diagnostic (IVD) use in Canada

0.1 mL concentrate 275R-14
0.5 mL concentrate 275R-15
1 mL concentrate 275R-16
1 mL predilute 275R-17
7 mL predilute 275R-18
25 mL predilute 275R-10

For in vitro diagnostic (IVD) use in Europe

0.1 mL concentrate 275R-14
0.5 mL concentrate 275R-15
1 mL concentrate 275R-16
1 mL predilute 275R-17
7 mL predilute 275R-18
25 mL predilute 275R-10

For research use only (RUO) in Japan

0.1 mL concentrate 275R-14-RUO
0.5 mL concentrate 275R-15-RUO
1 mL concentrate 275R-16-RUO
1 mL predilute 275R-17-RUO
7 mL predilute 275R-18-RUO
25 mL predilute 275R-10-RUO

 

To request information on this product in additional countries, please click the button below.

Specifications


  • Reactivity: paraffin
  • Visualization: nuclear
  • Control: tonsil
  • Isotype: lgG
  • Dilution Range: 1:100-1:500*

Protocols


  • Cell Marque HiDef
    T-PC/10-30minAb/HiDef/Perm Red
  • Cell Marque HiDef
    T-PC/10-30minAb/HiDef/DAB
  • Ventana ultraView
    UV/CC1S/32min @ 37°C

Download Package Insert

Select revision:


Keycode Specific Package Insert

Keycode:
Select prefix.
Please verify your keycode and try again. If problems presist contact Customer Service
Enter keycode.
Please verify your keycode and try again. If problems presist contact Customer Service

Some products may have special labeling requirements in the United States.

Are you located in the U.S.?


*Note: IFUs with the prefix RUO or ASR are only available for download in English.



Click here to learn about keycodes

Download SDS

References


  1. Mckeever P, et al. J Neuropathol Exp Neurol. 1998; 57:931-6.
  2. Coons SW, et al. Neurosurgery. 1997; 41:878-84.
  3. Allegra CJ, et al. J Clin Oncol. 2003; 21:241-50.
  4. Pathmanathan N, et al. J Clin Pathol. 2013; 66: 512-6.
  5. Swerdlow S, et al. WHO clarifications of tumours of hematopoietic and lymphoid tissues. 4th edition, 2008. P 220.
Request More Information